BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2004
View Archived Issues
Glucose-lowering effects of liraglutide in patients with type 2 diabetes
Read More
Update on the clinical benefits of rasagiline in PD
Read More
New data confirm Lovenox is effective antithrombotic for ACS
Read More
Ampligen study in HIV/hepatitis C coinfected patients to begin
Read More
Hemantane has protective effect in MPP+ model of Parkinson's
Read More
European marketing authorization for Vesicare for overactive bladder
Read More
Allergan files INDs for PEP-005 Topical
Read More
European approval for Pariet for Zollinger-Ellison syndrome
Read More
Phase I study for neuroprotectant KTX-0101
Read More
Isotechnika cleared to commence U.S. phase Ib study of TAFA-93
Read More
European orphan medicinal product status for Mepat in osteosarcoma
Read More
New phase III study for RSD-1235
Read More
Enrollment open at European sites in CoFactor phase II study
Read More
Celmed BioSciences completes acquisition of NewBiotics
Read More
Lorus expands Canadian prostate cancer study of GTI-2501 and docetaxel
Read More
Xoma reviews recent pipeline progress
Read More
Phosphodiesterase 4 inhibitors claimed by Memory Pharmaceuticals
Read More
Factor Xa and VIIa inhibitors reported by Merck KGaA
Read More
Vanilloid receptor antagonists for the treatment of pain
Read More
AstraZeneca describes glucokinase activators
Read More
Silicon compounds for GnRH related disorders
Read More
Bayer describes agents for hyperproliferative disorders
Read More
Lyrica approved in E.U.
Read More
A clinical trial evaluates the efficacy of montelukast in migraine prophylaxis
Read More
Antagonists of antiapoptotic protein for the treatment of cancer
Read More